Cargando…

Angiotensin‐Converting Enzyme‐2 Overexpression Improves Atrial Remodeling and Function in a Canine Model of Atrial Fibrillation

BACKGROUND: Atrial fibrosis is an important factor in initiating and maintaining atrial fibrillation. The purpose of this study was to test the hypothesis that atrial angiotensin‐converting enzyme‐2 (ACE2) overexpression might inhibit atrial collagen accumulation and improve atrial remodeling in a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tingquan, Wang, Zhenglong, Fan, Jinqi, Chen, Shaojie, Tan, Zhen, Yang, Hanxuan, Yin, Yuehui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392435/ https://www.ncbi.nlm.nih.gov/pubmed/25792125 http://dx.doi.org/10.1161/JAHA.114.001530

Ejemplares similares

Angiotensin-converting enzyme-2 overexpression improves atrial electrical remodeling through TRPM7 signaling pathway
por: Zhou, Tingquan, et al.
Publicado: (2017)

Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling: Fan, ACE2 improves atrial substrate remodeling
por: Fan, Jinqi, et al.
Publicado: (2015)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
por: Al-Seykal, Ibragim, et al.
Publicado: (2022)

Canagliflozin Suppresses Atrial Remodeling in a Canine Atrial Fibrillation Model
por: Nishinarita, Ryo, et al.
Publicado: (2021)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

DACT2 regulates structural and electrical atrial remodeling in atrial fibrillation
por: Hou, Jian, et al.
Publicado: (2020)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
por: Shariff, Nasir, et al.
Publicado: (2010)

Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting
por: Xu, Shu, et al.
Publicado: (2017)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension
por: Jiang, Min-Hui, et al.
Publicado: (2013)

Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes
por: Shu, Chenglin, et al.
Publicado: (2017)

Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation
por: Wang, Xuewen, et al.
Publicado: (2018)

Immune remodeling and atrial fibrillation
por: Yao, Yajun, et al.
Publicado: (2022)

Atrial extracellular matrix remodelling in patients with atrial fibrillation
por: Polyakova, V, et al.
Publicado: (2008)

A nomogram based on CHADS(2) score for predicting atrial fibrillation recurrence after cryoballoon ablation
por: Liu, Yu, et al.
Publicado: (2022)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
por: Batra, Gorav, et al.
Publicado: (2017)

Blockade of Exosome Release Suppresses Atrial Fibrillation by Alleviating Atrial Fibrosis in Canines With Prolonged Atrial Pacing
por: Yao, Yajun, et al.
Publicado: (2021)

Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model
por: Choi, Jong-Il, et al.
Publicado: (2016)

Atrial Electrical Remodeling in Mice With Cardiac‐Specific Overexpression of Angiotensin II Type 1 Receptor
por: Demers, Julie, et al.
Publicado: (2022)

Atrial Structural Remodeling Gene Variants in Patients with Atrial Fibrillation
por: Doñate Puertas, Rosa, et al.
Publicado: (2018)

Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis
por: Fragão-Marques, Mariana, et al.
Publicado: (2020)

Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease
por: Jansen, Hailey J., et al.
Publicado: (2020)

Cardio-Ankle Vascular Index and Atrial Remodeling for Atrial Fibrillation
por: Miyoshi, Toru
Publicado: (2021)

Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2022)

Is Right Atrial Remodeling an Additional Marker for the Progression of Atrial Fibrillation?
por: Park, Jin-Kyu
Publicado: (2023)

Histological validation of atrial structural remodelling in patients with atrial fibrillation
por: Takahashi, Yuya, et al.
Publicado: (2023)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model
por: Kiryu, Michiro, et al.
Publicado: (2012)

Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune response
por: Bernstein, Kenneth E., et al.
Publicado: (2016)

Effects of angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on one-year outcomes of patients with atrial fibrillation: insights from a multicenter registry study in China
por: LYU, Si-Qi, et al.
Publicado: (2020)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

The Early Stage of the Atrial Electroanatomic Remodeling as Substrates for Atrial Fibrillation in Hypertensive Patients
por: Yin, Xiaomeng, et al.
Publicado: (2014)

Blockade of SK4 channels suppresses atrial fibrillation by attenuating atrial fibrosis in canines with prolonged atrial pacing
por: Wang, Youcheng, et al.
Publicado: (2022)

Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy
por: Murakata, Yoshiko, et al.
Publicado: (2023)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
por: Zhu, Tianyu, et al.
Publicado: (2022)

Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients
por: Yang, Liu, et al.
Publicado: (2022)

Proarrhythmic Remodeling of Atrial Myocyte Ca(2+) Handling in Atrial Fibrillation
por: Houser, Steven R.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dhelef6r7cs4j75m2rpnorhdd8